NM_003184.4:c.3478A>G
Variant names:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_003184.4(TAF2):āc.3478A>Gā(p.Lys1160Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00000657 in 152,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 33)
Consequence
TAF2
NM_003184.4 missense
NM_003184.4 missense
Scores
4
7
8
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 6.29
Genes affected
TAF2 (HGNC:11536): (TATA-box binding protein associated factor 2) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the larger subunits of TFIID that is stably associated with the TFIID complex. It contributes to interactions at and downstream of the transcription initiation site, interactions that help determine transcription complex response to activators. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3003941).
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF2 | ENST00000378164.7 | c.3478A>G | p.Lys1160Glu | missense_variant | Exon 26 of 26 | 1 | NM_003184.4 | ENSP00000367406.2 | ||
TAF2 | ENST00000686879.1 | c.3634A>G | p.Lys1212Glu | missense_variant | Exon 27 of 27 | ENSP00000509206.1 | ||||
TAF2 | ENST00000685235.1 | c.3523A>G | p.Lys1175Glu | missense_variant | Exon 26 of 26 | ENSP00000510174.1 | ||||
TAF2 | ENST00000688645.1 | c.3367A>G | p.Lys1123Glu | missense_variant | Exon 25 of 25 | ENSP00000509978.1 | ||||
TAF2 | ENST00000523904.2 | c.3364A>G | p.Lys1122Glu | missense_variant | Exon 25 of 25 | 3 | ENSP00000430832.2 | |||
TAF2 | ENST00000690144 | c.*609A>G | 3_prime_UTR_variant | Exon 26 of 26 | ENSP00000510548.1 | |||||
TAF2 | ENST00000685202.1 | n.*1003A>G | non_coding_transcript_exon_variant | Exon 27 of 27 | ENSP00000509214.1 | |||||
TAF2 | ENST00000685503.1 | n.*2870A>G | non_coding_transcript_exon_variant | Exon 26 of 26 | ENSP00000509198.1 | |||||
TAF2 | ENST00000685663.1 | n.*3350A>G | non_coding_transcript_exon_variant | Exon 28 of 28 | ENSP00000508988.1 | |||||
TAF2 | ENST00000685684.1 | n.*4945A>G | non_coding_transcript_exon_variant | Exon 25 of 25 | ENSP00000509441.1 | |||||
TAF2 | ENST00000685824.1 | n.*3179A>G | non_coding_transcript_exon_variant | Exon 24 of 24 | ENSP00000510262.1 | |||||
TAF2 | ENST00000685876.1 | n.*3196A>G | non_coding_transcript_exon_variant | Exon 27 of 27 | ENSP00000510493.1 | |||||
TAF2 | ENST00000685993.1 | n.*3293A>G | non_coding_transcript_exon_variant | Exon 25 of 25 | ENSP00000510102.1 | |||||
TAF2 | ENST00000686098.1 | n.*2123A>G | non_coding_transcript_exon_variant | Exon 25 of 25 | ENSP00000509102.1 | |||||
TAF2 | ENST00000688037.1 | n.*2897A>G | non_coding_transcript_exon_variant | Exon 23 of 23 | ENSP00000510169.1 | |||||
TAF2 | ENST00000689919.1 | n.*3085A>G | non_coding_transcript_exon_variant | Exon 26 of 26 | ENSP00000510768.1 | |||||
TAF2 | ENST00000690808.1 | n.*2714A>G | non_coding_transcript_exon_variant | Exon 26 of 26 | ENSP00000509791.1 | |||||
TAF2 | ENST00000690922.1 | n.*1890A>G | non_coding_transcript_exon_variant | Exon 26 of 26 | ENSP00000509498.1 | |||||
TAF2 | ENST00000691880.1 | n.*3134A>G | non_coding_transcript_exon_variant | Exon 25 of 25 | ENSP00000508515.1 | |||||
TAF2 | ENST00000692518.1 | n.*3344A>G | non_coding_transcript_exon_variant | Exon 25 of 25 | ENSP00000508959.1 | |||||
TAF2 | ENST00000692707.1 | n.*3346A>G | non_coding_transcript_exon_variant | Exon 28 of 28 | ENSP00000509024.1 | |||||
TAF2 | ENST00000692916.1 | n.*2865A>G | non_coding_transcript_exon_variant | Exon 25 of 25 | ENSP00000509603.1 | |||||
TAF2 | ENST00000685202.1 | n.*1003A>G | 3_prime_UTR_variant | Exon 27 of 27 | ENSP00000509214.1 | |||||
TAF2 | ENST00000685503.1 | n.*2870A>G | 3_prime_UTR_variant | Exon 26 of 26 | ENSP00000509198.1 | |||||
TAF2 | ENST00000685663.1 | n.*3350A>G | 3_prime_UTR_variant | Exon 28 of 28 | ENSP00000508988.1 | |||||
TAF2 | ENST00000685684.1 | n.*4945A>G | 3_prime_UTR_variant | Exon 25 of 25 | ENSP00000509441.1 | |||||
TAF2 | ENST00000685824.1 | n.*3179A>G | 3_prime_UTR_variant | Exon 24 of 24 | ENSP00000510262.1 | |||||
TAF2 | ENST00000685876.1 | n.*3196A>G | 3_prime_UTR_variant | Exon 27 of 27 | ENSP00000510493.1 | |||||
TAF2 | ENST00000685993.1 | n.*3293A>G | 3_prime_UTR_variant | Exon 25 of 25 | ENSP00000510102.1 | |||||
TAF2 | ENST00000686098.1 | n.*2123A>G | 3_prime_UTR_variant | Exon 25 of 25 | ENSP00000509102.1 | |||||
TAF2 | ENST00000688037.1 | n.*2897A>G | 3_prime_UTR_variant | Exon 23 of 23 | ENSP00000510169.1 | |||||
TAF2 | ENST00000689919.1 | n.*3085A>G | 3_prime_UTR_variant | Exon 26 of 26 | ENSP00000510768.1 | |||||
TAF2 | ENST00000690808.1 | n.*2714A>G | 3_prime_UTR_variant | Exon 26 of 26 | ENSP00000509791.1 | |||||
TAF2 | ENST00000690922.1 | n.*1890A>G | 3_prime_UTR_variant | Exon 26 of 26 | ENSP00000509498.1 | |||||
TAF2 | ENST00000691880.1 | n.*3134A>G | 3_prime_UTR_variant | Exon 25 of 25 | ENSP00000508515.1 | |||||
TAF2 | ENST00000692518.1 | n.*3344A>G | 3_prime_UTR_variant | Exon 25 of 25 | ENSP00000508959.1 | |||||
TAF2 | ENST00000692707.1 | n.*3346A>G | 3_prime_UTR_variant | Exon 28 of 28 | ENSP00000509024.1 | |||||
TAF2 | ENST00000692916.1 | n.*2865A>G | 3_prime_UTR_variant | Exon 25 of 25 | ENSP00000509603.1 | |||||
TAF2 | ENST00000689164.1 | n.*4096A>G | downstream_gene_variant | ENSP00000508729.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152194Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152194
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74364
GnomAD4 genome
AF:
AC:
1
AN:
152194
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74364
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Pathogenic
D;D
Sift4G
Uncertain
D;D
Polyphen
P;.
Vest4
MutPred
Loss of methylation at K1160 (P = 0.0047);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at